102 related articles for article (PubMed ID: 38843660)
1. A nomogram based on pretreatment radiomics and dosiomics features for predicting overall survival associated with esophageal squamous cell cancer.
Kawahara D; Nishioka R; Murakami Y; Emoto Y; Iwashita K; Sasaki R
Eur J Surg Oncol; 2024 Jun; 50(7):108450. PubMed ID: 38843660
[TBL] [Abstract][Full Text] [Related]
2. Radiomics and dosiomics for predicting complete response to definitive chemoradiotherapy patients with oesophageal squamous cell cancer using the hybrid institution model.
Kawahara D; Murakami Y; Awane S; Emoto Y; Iwashita K; Kubota H; Sasaki R; Nagata Y
Eur Radiol; 2024 Feb; 34(2):1200-1209. PubMed ID: 37589902
[TBL] [Abstract][Full Text] [Related]
3. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
[TBL] [Abstract][Full Text] [Related]
4. CT-based radiomics combined with hematologic parameters for survival prediction in locally advanced esophageal cancer patients receiving definitive chemoradiotherapy.
Cui J; Zhang D; Gao Y; Duan J; Wang L; Li L; Yuan S
Insights Imaging; 2024 Mar; 15(1):87. PubMed ID: 38523188
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of an
Huang J; Li T; Tang L; Hu Y; Hu Y; Gu Y
Acad Radiol; 2024 Jun; ():. PubMed ID: 38845294
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of
Wang B; Liu J; Zhang X; Wang Z; Cao Z; Lu L; Lv W; Wang A; Li S; Wu X; Dong X
EJNMMI Res; 2023 Feb; 13(1):14. PubMed ID: 36779997
[TBL] [Abstract][Full Text] [Related]
7. Radiation pneumonitis prediction with dual-radiomics for esophageal cancer underwent radiotherapy.
Li C; Zhang J; Ning B; Xu J; Lin Z; Zhang J; Tan N; Yu X; Su W; Ni W; Yu W; Wu J; Cao G; Cao Z; Xie C; Jin X
Radiat Oncol; 2024 Jun; 19(1):72. PubMed ID: 38851718
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a
Liu H; Cui Y; Chang C; Zhou Z; Zhang Y; Ma C; Yin Y; Wang R
BMC Cancer; 2024 Jan; 24(1):150. PubMed ID: 38291351
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Chen YY; Huang WZ; Wu SX; Huang SF; Xu HY; Xue RL; Du ZS; Li XY; Lin LX; Huang HC
Radiat Oncol; 2021 Oct; 16(1):201. PubMed ID: 34641928
[TBL] [Abstract][Full Text] [Related]
10.
Hu S; Kang Y; Xie Y; Yang T; Yang Y; Jiao J; Zou Q; Zhang H; Zhang Y
Abdom Radiol (NY); 2023 Feb; 48(2):532-542. PubMed ID: 36370179
[TBL] [Abstract][Full Text] [Related]
11. Radiomics-clinical nomogram based on pretreatment 18F-FDG PET-CT radiomics features for individualized prediction of local failure in nasopharyngeal carcinoma.
Ding J; Li Z; Lin Y; Huang C; Chen J; Hong J; Fei Z; Zhou Q; Chen C
Sci Rep; 2023 Oct; 13(1):18167. PubMed ID: 37875498
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Radiomics Nomogram Based on
Yang B; Zhong J; Zhong J; Ma L; Li A; Ji H; Zhou C; Duan S; Wang Q; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G
Front Oncol; 2020; 10():1042. PubMed ID: 32766134
[No Abstract] [Full Text] [Related]
13. CT radiomics in the identification of preoperative understaging in patients with clinical stage T1-2N0 esophageal squamous cell carcinoma.
Zhao B; Yan S; Jia ZY; Zhu HT; Shi YJ; Li XT; Qu JR; Sun YS
Quant Imaging Med Surg; 2023 Dec; 13(12):7996-8008. PubMed ID: 38106287
[TBL] [Abstract][Full Text] [Related]
14. Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signatures.
Cui Y; Li Z; Xiang M; Han D; Yin Y; Ma C
Radiat Oncol; 2022 Dec; 17(1):212. PubMed ID: 36575480
[TBL] [Abstract][Full Text] [Related]
15.
Xue XQ; Yu WJ; Shi X; Shao XL; Wang YT
Front Oncol; 2022; 12():911168. PubMed ID: 36003788
[TBL] [Abstract][Full Text] [Related]
16. CT radiomics features of meso-esophageal fat in predicting overall survival of patients with locally advanced esophageal squamous cell carcinoma treated by definitive chemoradiotherapy.
Yan S; Li FP; Jian L; Zhu HT; Zhao B; Li XT; Shi YJ; Sun YS
BMC Cancer; 2023 May; 23(1):477. PubMed ID: 37231388
[TBL] [Abstract][Full Text] [Related]
17. Dosiomics and radiomics improve the prediction of post-radiotherapy neutrophil-lymphocyte ratio in locally advanced non-small cell lung cancer.
Hou R; Xia W; Zhang C; Shao Y; Zhu X; Feng W; Zhang Q; Yu W; Fu X; Zhao J
Med Phys; 2024 Jan; 51(1):650-661. PubMed ID: 37963229
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of
Song Y; Tian Y; Lu X; Chen G; Lv X
Med Phys; 2024 Jan; ():. PubMed ID: 38252704
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of a Radiomics Nomogram Model for Predicting Postoperative Recurrence in Patients With Esophageal Squamous Cell Cancer Who Achieved pCR After Neoadjuvant Chemoradiotherapy Followed by Surgery.
Qiu Q; Duan J; Deng H; Han Z; Gu J; Yue NJ; Yin Y
Front Oncol; 2020; 10():1398. PubMed ID: 32850451
[No Abstract] [Full Text] [Related]
20. The value of
Ma J; Guo D; Miao W; Wang Y; Yan L; Wu F; Zhang C; Zhang R; Zuo P; Yang G; Wang Z
Abdom Radiol (NY); 2022 Apr; 47(4):1244-1254. PubMed ID: 35218381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
